Gabapentin may become a Schedule V controlled substance in some jurisdictions. Which option correctly reflects this possibility?

• A. Schedule II drug
• B. Schedule V drug
• C. Non-controlled substance
• D. Schedule IV drug

Answer: (B)

Drug scheduling is a regulatory process that varies by jurisdiction, and authorities can reclassify substances based on medical use and abuse risk. Gabapentin has legitimate medical uses, but some jurisdictions have moved to place it under Schedule V or are considering it, reflecting a recognition of some abuse potential while still allowing medical use with monitoring. Schedule V is the lowest level of controlled substances that still imposes regulatory controls, such as prescription requirements and record-keeping, aimed at preventing misuse without treating the drug the same as more tightly controlled substances. That makes Schedule V the best reflection of the possibility described. Higher schedules (like II or IV) would imply greater abuse potential or tighter restrictions than Schedule V, and non-controlled would mean no regulatory controls at all, which doesn't capture the possibility that some places would regulate gabapentin.